Ackman exits Valeant position…stock tanks

Bill Ackman’s Pershing Square has exited his 5.3% position in Valeant Pharmaceuticals (VRX), selling 27.2 million shares at about $11 [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Sightings…

Alice Ruth, who had been the chief investment officer at Willett Advisors, Michael Bloomberg’s family office and foundation, has been [Read More]
To access this content, you must be a member. Visit the Plans page for details.

University of Michigan to vote on allocations to Granite State Capital, Matrix Capital and Brevet Capital

At its upcoming meeting on Thursday, the University of Michigan Regents will vote on allocating to three hedge funds – [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Icahn increases stake in Herbalife, stock climbs higher

According to an SEC filing today, Carl Icahn has bought another 372,342 shares of Herbalife (HLF) at $51.35 per share, [Read More]
To access this content, you must be a member. Visit the Plans page for details.

Major Factors Influencing Investment Returns and Opportunities in 2017

Partners Capital, which acts as an outsourced investment officer for endowments, foundations and ultra-high net worth families and manages more [Read More]
To access this content, you must be a member. Visit the Plans page for details.